Impedimed Limited ( (AU:IPD) ) just unveiled an announcement.
Impedimed Limited announced a change in the director’s interest, with Fiona Bones acquiring an additional 197,647 ordinary shares, bringing her total to 1,506,230 shares. This acquisition was made through the issue of shares in lieu of 30% of director fees for the quarter ended March 31, 2025, reflecting a strategic approach to compensation and potentially strengthening the director’s alignment with shareholder interests.
More about Impedimed Limited
Impedimed Limited operates in the medical technology industry, focusing on developing and providing non-invasive medical devices for the assessment of body composition and fluid status. The company’s primary products are used in healthcare settings to aid in the diagnosis and management of conditions such as lymphedema and heart failure, with a market focus on improving patient outcomes through innovative technology.
YTD Price Performance: -44.44%
Average Trading Volume: 74,308
Technical Sentiment Signal: Buy
Current Market Cap: $44M
See more insights into IPD stock on TipRanks’ Stock Analysis page.